| |
|
|
|
Capricor Therap  
|
|
5.3 0.32 (0.06%) |
09-25 16:00 |
|
Open: |
5.02 |
Pre close: |
4.98 |
Target:
|
6.62
|
|
High: |
5.32 |
Low: |
5.0123 |
Resistance:
|
5.66
6.57
|
|
Volume: |
493,082 |
Market Cap: |
105M |
Support:
|
4.20
3.49
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.18
 |
MACD |
MACD(12,26):
|
-0.18  |
|
MA(20): |
5.15 |
Signal(12,26,9): |
-0.25 |
|
MA(100): |
5.64 |
Stochastic Oscillator |
%K(14,3):
|
39.24 |
|
MA(250): |
3.40 |
%D(3): |
40.27 |
|
Average Volume(K) |
3-Month: |
285249
|
52-Week |
High:
|
12.32 |
|
10-Days: |
177737 |
Low: |
0.88 |
|
RSI |
RSI(14):
|
49.01 |
Change(%): |
43.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.149 |
Return on Equity (ttm) |
-50.8 |
Shares Out. (M) |
19.72 |
|
EPS Est. Current Year |
-0.700 |
Return on Assets (ttm) |
-24.5 |
Shares Float (M) |
19.22 |
|
EPS Est. Next Year |
-0.760 |
PEG Ratio |
0.00 |
% Held by Insiders |
9.21 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
-87.8 |
% Held by Institutions |
3.69 |
|
Forward EPS |
-2.060 |
Gross Profit (p.s.) |
-0.210 |
Shares Short (K) |
1920 |
|
Book Value (p.s.) |
1.610 |
EBITDA (p.s.) |
-0.434 |
P/E |
-4.61 |
|
Sales Per Share |
0.030 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.29 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.67 |
P/S |
174.27 |
|
Operating Margin |
-1451.72 |
Levered Free Cash Flow
(M) |
-3.39 |
P/CF |
-15.67 |
|
|
|
|
|
|
